| |||||||||
Former Names B6.Cg(CB)-Tg(HLA-A/H2-D)2Enge/J (Changed: 15-DEC-04 ) Type Congenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered Mutant Mice. Mating System Hemizygote x Hemizygote (Female x Male) Species laboratory mouse Generation NE11F9 (31-DEC-07) Donating Investigator Victor Engelhard, University of Virginia Description
Mice homozygous for the transgenic insert are viable, fertile, normal in size and do not display any gross physical or behavioral abnormalities. These transgenic mice express an interspecies hybrid class I MHC gene, AAD, which contains the alpha-1 and alpha-2 domains of the human HLA-A2.1 gene and the alpha-3 transmembrane and cytoplasmic domains of the mouse H-2Dd gene, under the direction of the human HLA-A2.1 promoter. Immunodetection of the HLA-A2.1 recombinant transgene established that expression was at equivalent levels to endogenous mouse class I molecules. The mouse alpha-3 domain expression enhances the immune response in this system. Compared to unmodified HLA-A2.1, the chimeric HLA-A2.1/H2-Dd MHC Class I molecule mediates efficient positive selection of mouse T cells to provide a more complete T cell repertoire capable of recognizing peptides presented by HLA-A2.1 Class I molecules. The peptide epitopes presented and recognized by mouse T cells in the context of the HLA-A2.1/H2-Dd class I molecule are the same as those presented in HLA-A2.1+ humans. This transgenic strain enables the modeling of human T cell immune responses to HLA-A2 presented antigens, and identification of those antigens. This transgenic strain is an important preclinical model for design and testing of vaccines for infectious diseases or cancer therapy involving optimal stimulation of Cd8+ cytolytic T cells.Development
A transgenic construct containing the leader, alpha-1 and alpha-2 domains of human HLA-A2.1 and the alpha-3 transmembrane and cytoplasmic domains of mouse H-2Dd was injected into fertilized (C57BL/6 X CBA/Ca)F1 mouse eggs. Founder animals were bred with C57BL/6 mice.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of HLA-A
View Strains carrying other alleles of HLA-A (9 strains)
Congenic Nomenclature
Genetic Quality Control Annual Report
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Tg(HLA-A/H2-D)2Enge/?
(C57BL/6 x CBA)F1
- immune system phenotype
- abnormal cytotoxic T cell physiology (MGI Ref ID J:31937)
- CD8 T cells from influenza infected transgenic mice lyse target cells presenting influenza peptide on either human HLA-A2.1 (MHC-I) or chimeric human mouse HLA-A/H2-D (MHC-I) complexes
- CD8 T cells lyse target cells expressing the chimeric MHC-I complex with 10-fold higher efficiency compared to target cell expressing the human MHC-I complex
- abnormal negative T cell selection (MGI Ref ID J:31937)
- T cells that recognize the human MHC-1 complex HLA-A2.1 are not negatively selected
- abnormal positive T cell selection (MGI Ref ID J:31937)
- positive selection of T cells capable of responding to antigen presented by chimeric MHC-1 complexes is enhanced compared to selection in Tg(HLA-A2.1)1Enge mice that express human MHC-1
- the chimeric MHC Class I molecule mediates efficient positive selection of mouse T cells to provide a more complete T cell repertoire capable of recognizing peptides presented by HLA-A2.1 Class I molecules.
- The peptide epitopes presented and recognized by mouse T cells in the context of the HLA-A2.1/H2-Dd class I molecule are the same as those presented in HLA-A2.1+ humans.
- hematopoietic system phenotype
- abnormal negative T cell selection (MGI Ref ID J:31937)
- T cells that recognize the human MHC-1 complex HLA-A2.1 are not negatively selected
- abnormal positive T cell selection (MGI Ref ID J:31937)
- positive selection of T cells capable of responding to antigen presented by chimeric MHC-1 complexes is enhanced compared to selection in Tg(HLA-A2.1)1Enge mice that express human MHC-1
- the chimeric MHC Class I molecule mediates efficient positive selection of mouse T cells to provide a more complete T cell repertoire capable of recognizing peptides presented by HLA-A2.1 Class I molecules.
- The peptide epitopes presented and recognized by mouse T cells in the context of the HLA-A2.1/H2-Dd class I molecule are the same as those presented in HLA-A2.1+ humans.
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
HLA-A relatedResearch Tools
Cancer Research (production of B and T cells, antibodies, and hybridomas)
Cancer Research (production of T cells and hybridoma)
Cancer Research (tumor immunology)
Cancer Research (xenograft/transplant host)
Developmental Biology Research (transplantation marker for embryonic and adult tissue)
Genetics Research (Tissue/Cell Markers: cell marker for bone marrow transplantation)
Immunology and Inflammation Research
CD Antigens, Antigen Receptors, and Histocompatibility Markers
Vaccine Development
| Allele Symbol | Tg(HLA-A/H2-D)2Enge | ||
|---|---|---|---|
| Allele Name | transgene insertion 2, Victor H Engelhard | ||
| Allele Type | Transgenic (random, expressed) | ||
| Common Name(s) | AAD mice; | ||
| Mutation Made By | Victor Engelhard, University of Virginia | ||
| Strain of Origin | (C57BL/6 x CBA/Ca)F1 | ||
| Expressed Gene | HLA-A, major histocompatibility complex, class I, A, human | ||
| Molecular Note | Transgenic mice express an interspecies hybrid class I MHC gene, AAD, which contains the alpha-1 and alpha-2 domains of the human HLA-A2.1 gene and the alpha-3 transmembrane and cytoplasmic domains of the murine H-2D gene, under the direction of the human HLA-A2.1 promoter. Immunodetection of the HLA-A2.1 recombinant transgene established that expression was at equivalent levels to endogenous murine class I molecules and to similar transgenic strains. [MGI Ref ID J:31937] | ||
Genotyping Protocols
Tg(HLA-A/H2-D), QPCR, vers. 2
Tg(HLA-A/H2-D), STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Newberg MH; Smith DH; Haertel SB; Vining DR; Lacy E; Engelhard VH. 1996. Importance of MHC class 1 alpha2 and alpha3 domains in the recognition of self and non-self MHC molecules. J Immunol 156(7):2473-80. [PubMed: 8786307] [MGI Ref ID J:31937]
Tg(HLA-A/H2-D)2Enge relatedLengagne R; Graff-Dubois S; Garcette M; Renia L; Kato M; Guillet JG; Engelhard VH; Avril MF; Abastado JP; Prevost-Blondel A. 2008. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases. J Immunol 180(1):130-7. [PubMed: 18097012] [MGI Ref ID J:130879]
Qian J; Dong Y; Pang YY; Ibrahim R; Berzofsky JA; Schiller JT; Khleif SN. 2006. Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 mice. Int J Cancer 118(12):3022-9. [PubMed: 16425257] [MGI Ref ID J:112324]
Animal Health Reports
Room Number AX12
Colony Maintenance
Breeding & Husbandry Founder mice were backcrossed to C57BL/6 animals for at least 10 generation before being made homozygous. Mating System Hemizygote x Hemizygote (Female x Male) Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $236.40 Female or Male Hemizygous for Tg(HLA-A/H2-D)2Enge $236.40 Female or Male Homozygous for Tg(HLA-A/H2-D)2Enge *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $472.80 Hemizygous for Tg(HLA-A/H2-D)2Enge x Hemizygous for Tg(HLA-A/H2-D)2Enge
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $307.40 Female or Male Hemizygous for Tg(HLA-A/H2-D)2Enge $307.40 Female or Male Homozygous for Tg(HLA-A/H2-D)2Enge *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $614.70 Hemizygous for Tg(HLA-A/H2-D)2Enge x Hemizygous for Tg(HLA-A/H2-D)2Enge
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.